Implementing Socially Responsible Licensing for Global Health: Beyond Neglected Diseases

See allHide authors and affiliations

Science Translational Medicine  29 Oct 2014:
Vol. 6, Issue 260, pp. 260cm11
DOI: 10.1126/scitranslmed.3009422


Global health efforts require socially responsible licensing that permits wide-ranging access to inventions that address health challenges beyond the so-called neglected diseases. Our analysis suggests that universities that excel in global health innovation are less likely to have global-access licensing policies in place. This trend can slow access to new clinical products and diminish the ability of universities to address their public missions.

View Full Text

Stay Connected to Science Translational Medicine